Literature DB >> 7805724

Heterogeneity in P-glycoprotein (multidrug resistance) activity among murine peripheral T cells: correlation with surface phenotype and effector function.

U Bommhardt1, J C Cerottini, H R MacDonald.   

Abstract

P-glycoprotein (P-gly) is the transmembrane efflux pump responsible for multidrug resistance in tumor cells. Functional P-gly activity can be conveniently assessed microfluorometrically using the fluorescent dye rhodamine 123 (Rh123), which is an artificial substrate for the P-gly transporter. Here we assess P-gly activity in subsets of mouse peripheral T lymphocytes using the Rh123 efflux assay. Our data indicate that virtually all CD8+ cells extrude Rh123 efficiently, whereas only a subset of CD4+ cells exhibit P-gly activity. Correlation of P-gly activity in CD4+ cells with the expression of a panel of surface markers revealed that cells bearing an "activated/memory" phenotype (CD45RB-, CD44hi, CD62L-, CD25+, CD69+) were exclusively found in the fraction that can extrude Rh123. In contrast "naive" phenotype CD4+ cells (CD45RB+, CD44lo, CD62L+, CD25-, CD69-) could be further subdivided into two major subsets based on P-gly activity. In functional studies of sorted cell populations the Rh123-extruding subset of "naive" CD4+ cells proliferated more strongly and secreted higher levels of interleukin (IL)-2 than its Rh123-retaining counterpart when activated by a variety of polyclonal stimuli. Furthermore, this subset produced detectable levels of interferon (IFN)-gamma upon stimulation but no IL-4 or IL-10. As expected, the Rh123-retaining "naive" subset produced only IL-2 after stimulation, whereas the "memory" subset produced IFN-gamma, IL-4 and IL-10 in addition to low levels of IL-2. Collectively, our data indicate that P-gly activity is a novel parameter that can be used to distinguish a subset of "preactivated" CD4+ cells that would be considered as naive on the basis of their surface phenotype.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805724     DOI: 10.1002/eji.1830241208

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.

Authors:  Katharine H Banner; Christophe Cattaneo; Jean-Loic Le Net; Aleksandar Popovic; David Collins; Jeremy D Gale
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

2.  Antigen-independent changes in naive CD4 T cells with aging.

Authors:  P J Linton; L Haynes; N R Klinman; S L Swain
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

3.  Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.

Authors:  A H Schinkel; U Mayer; E Wagenaar; C A Mol; L van Deemter; J J Smit; M A van der Valk; A C Voordouw; H Spits; O van Tellingen; J M Zijlmans; W E Fibbe; P Borst
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay.

Authors:  H Kobayashi; Y Takemura; H Miyachi; M Kawabata; S Mori; Y Kawai; K Furihata; S Sekiguchi; K Watanabe
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

5.  P-glycoprotein and alloimmune T-cell activation.

Authors:  Shona S Pendse; David M Briscoe; Markus H Frank
Journal:  Clin Appl Immunol Rev       Date:  2003-07

6.  Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier.

Authors:  P J Gaillard; I C van der Sandt; L H Voorwinden; D Vu; J L Nielsen; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

7.  A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th) 2, but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo.

Authors:  M Lohoff; S Prechtl; F Sommer; M Roellinghoff; E Schmitt; G Gradehandt; P Rohwer; B D Stride; S P Cole; R G Deeley
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

8.  Multidrug transporter activity in lymphocytes.

Authors:  James I Elliott; Selina Raguz; Christopher F Higgins
Journal:  Br J Pharmacol       Date:  2004-10-18       Impact factor: 8.739

9.  Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

Authors:  U Mayer; E Wagenaar; B Dorobek; J H Beijnen; P Borst; A H Schinkel
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 10.  P-glycoprotein and drug resistance in systemic autoimmune diseases.

Authors:  Andrea Picchianti-Diamanti; Maria Manuela Rosado; Marco Scarsella; Bruno Laganà; Raffaele D'Amelio
Journal:  Int J Mol Sci       Date:  2014-03-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.